Come up with a name for your new list and we'll add to it:
Immune Cell Therapy raised a round of funding on , . Investors include
Capital Midwest Fund.
ICT is developing a personalized vaccine treatment to help cancer from recurring. A small amount of the patient's own primary tumor is used to prepare the vaccine, so that the vaccine targets the spec…